Empagliflozin in the treatment of type 2 diabetes: evidence to date

Overview of attention for article published in Drug Design, Development and Therapy, October 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

patent: 1 patent

wikipedia: 7 Wikipedia pages

Citations

dimensions_citation: 68 Dimensions

Readers on

mendeley: 125 Mendeley

Summary Patents Wikipedia Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

SGLT-2 INHIBITOR FOR USE IN THE TREATMENT OF A METABOLIC MYOPATHY

Grant EP-3362055-B1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.